Stockscreener 앱 받기
0.194
12.22%
-0.027
시장 영업 전:
.20
0.006
+3.09%
전일 마감가:
$0.221
열려 있는:
$0.2281
하루 거래량:
2.21M
Relative Volume:
8.66
시가총액:
$11.34M
수익:
-
순이익/손실:
$-8.09M
주가수익비율:
-1.199
EPS:
-0.1618
순현금흐름:
$-8.31M
1주 성능:
-11.42%
1개월 성능:
-29.30%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$0.1846
$0.2498
1주일 범위
$0.1846
$0.2498
52주 변동 폭
$0.1846
$5.13
Abpro Holdings Inc Stock (ABP) Company Profile
명칭
Abpro Holdings Inc
전화
248-890-7200
주소
6 ST JOHNS LANE, FLOOR 5, NEW YORK
ABP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABP
Abpro Holdings Inc
|
0.194 | 11.34M | 0 | -8.09M | -8.31M | -0.1618 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.60 | 128.25B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.67 | 63.70B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
569.12 | 39.07B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
258.35 | 33.27B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
235.94 | 27.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Abpro Holdings Inc 주식(ABP)의 최신 뉴스
Abpro Holdings CEO Suk Jin Wook buys shares worth $1,081 By Investing.com - Investing.com Canada
Abpro Holdings CEO Suk Jin Wook buys shares worth $1,081 - Investing.com Australia
ABP stock plunges to 52-week low, touches $0.23 - Investing.com
Holdings of Abpro Holdings Inc (ABP) are aligned with the stars - Sete News
Closing Strong: Abpro Holdings Inc (ABP) Ends at 0.26, Down -0.27 from Last Close - DWinneX
Abpro Holdings Inc’s latest rating changes from various analysts - knoxdaily.com
Abpro Holdings Celebrates Closing of Business Combination with Nasdaq Bell Ringing - ADVFN
ABP’s Stock Journey: What Investors Need to Know About Abpro Holdings Inc’s Performance - investchronicle.com
Analyzing ABP’s price-to-book ratio for the last quarter - uspostnews.com
Abpro Holdings Presents Promising Preclinical Cancer Data - TipRanks
Why Amplify Energy Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket - Benzinga
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager - The Manila Times
Abpro and Celltrion Reveal Promising Preclinical Data for Bispecific T-Cell Engager ABP-102/CT-P72 Targeting HER2-Positive Cancers - Nasdaq
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing - Bluefield Daily Telegraph
Cancer Drug Shows 2X Better Tumor Suppression in Breakthrough Study | ABP Stock News - Stock Titan
Abpro Holdings CEO Acquires Additional Shares - TradingView
Stocks in play: A&W Food Services of Canada Inc - The Globe and Mail
Abpro Holdings amends convertible note terms with Yorkville - Investing.com
Abpro Holdings amends convertible note terms with Yorkville By Investing.com - Investing.com Canada
ABP stock plunges to 52-week low, touches $0.23 By Investing.com - Investing.com South Africa
Abpro Holdings identifies errors, to restate prior financials By Investing.com - Investing.com South Africa
Abpro Holdings identifies errors, to restate prior financials - Investing.com Australia
Abpro Holdings, Inc. SEC 10-K Report - TradingView
Abpro Holdings approves significant stock issuance to Yorkville - Investing.com Australia
Abpro Holdings approves significant stock issuance to Yorkville By Investing.com - Investing.com South Africa
Abpro Holdings faces Nasdaq delisting over share price By Investing.com - Investing.com South Africa
Abpro Holdings faces Nasdaq delisting over share price - Investing.com
Abpro Holdings Delays Year-End Financial Report - TipRanks
Abpro Holdings to Present Preclinical Data at AACR 2025 - TipRanks
Abpro Announces Oral Presentation of First Preclinical Data for ABP-102/CT-P72, a Tetravalent Bispecific HER2 x CD3 T-Cell Engager, at AACR Annual Meeting 2025 - The Manila Times
Groundbreaking Cancer Treatment Data: Abpro's HER2 Therapy Selected for Major AACR Showcase - Stock Titan
Abpro Chief Executive Ian Chan Departs -March 11, 2025 at 04:42 am EDT - Marketscreener.com
Abpro Statement on the Departure of Former CEO Ian Chan - The Manila Times
3 Stocks Primed for Compounding Wealth This Decade - The Globe and Mail
Why Oil and Gas Giants ExxonMobil, Chevron, and ConocoPhilips Were Down Today on an Up Day for the Market - The Globe and Mail
Reaction to Tariffs Was as Expected - The Globe and Mail
European and U.S. Futures Rise Amid Optimism Over Inflation Data and Tariff Developments - The Globe and Mail
Design Software Stocks Q4 Teardown: Adobe (NASDAQ:ADBE) Vs The Rest - The Globe and Mail
Abpro Holdings Inc Terminates Ian Chan As CEO Effective March 3, 2025 - MarketScreener
Delek Logistics Partners' Q4 Earnings Increase, Revenue Declines -February 25, 2025 at 07:41 am EST - Marketscreener.com
Abpro (NASDAQ:ABP) Now Covered by Analysts at Maxim Group - Defense World
Maxim Group Initiates Coverage of Abpro Holdings (ABP) with Buy Recommendation - Nasdaq
Equitable Holdings Launches $1.8 Billion Tender Offer for AllianceBernstein Units -February 24, 2025 at 06:39 am EST - Marketscreener.com
What To Expect From Myriad Genetics’s (MYGN) Q4 Earnings - The Globe and Mail
Abpro Holdings Highlights Strategic Partnerships in Biotech - TipRanks
Abpro Holdings Inc (ABP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.73%
1.07%
자본화:
|
볼륨(24시간):